2,4-dichloro-6-(2,6-dimethylphenoxy)-1,3,5-triazine | 52643-07-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2,4-dichloro-6-(2,6-dimethylphenoxy)-1,3,5-triazine
• CAS: 52643-07-9
• 化学式: C₁₁H₉Cl₂N₃O
• 分子量: 270.118
• InChiKey: UIGMDMOGAQFIQT-UHFFFAOYSA-N

物化性质

• 沸点：
  442.8±55.0 °C(Predicted)
• 密度：
  1.377±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  47.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2,4-dichloro-6-(2,6-dimethylphenoxy)-1,3,5-triazine 在 ammonium hydroxide 作用下， 以 丙酮 为溶剂， 反应 12.0h， 以89%的产率得到4-Chloro-6-(2,6-dimethylphenoxy)-1,3,5-triazin-2-amine
  参考文献：
  名称：

  Ｈｓｐ９０ 억제 활성을 갖는 신규 페녹시트리아진계 화합물 또는 이의 약제학적으로 허용가능한 염 및 이의 의학적 용도

  摘要：

  本发明涉及具有Hsp90抑制活性的新型苯氧三嗪类化合物或其药学上可接受的盐及其医药用途。所述苯氧三嗪类化合物具有优异的Hsp90抑制效果，通过抑制Hsp90可诱导Hsp90客户蛋白的分解，从而用于治疗或预防Hsp90介导的疾病，如癌症或退行性神经疾病，作为药物或保健品非常有用。

  公开号：

  KR20150004121A
• 作为产物：
  描述：

  三聚氯氰 、 2,6-二甲基苯酚 生成 2,4-dichloro-6-(2,6-dimethylphenoxy)-1,3,5-triazine
  参考文献：
  名称：

  DISUBSTITUTED TRIAZINE DIMERS FOR TREATMENT AND/OR PREVENTION OF INFECTIOUS DISEASES

  摘要：

  本发明涉及新型化合物（I），其中包含两个二取代三嗪环通过有机连接剂共价连接形成二聚体。这些化合物对非洲锥虫病、恙虫病、利什曼病、疟疾和艾滋病等感染性疾病的致病微生物具有活性。本发明还涉及这些疾病的预防和/或治疗。

  公开号：

  US20140323488A1

文献信息

• THERAPEUTIC COMPOUNDS
  申请人：CELGENE QUANTICEL RESEARCH, INC.

  公开号：US20170298040A1

  公开（公告）日：2017-10-19

  The present disclosure relates to substituted heterocyclic derivative therapeutic compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of diseases mediated by aberrant cell signalling, such as inflammatory disorders, cancer and neoplastic disease.

  本公开涉及替代杂环衍生治疗化合物，包括所述化合物的组合物，以及通过抑制溴结构域介导的乙酰赖氨酸区域对蛋白质（如组蛋白）的识别来进行表观遗传调控的所述化合物和组合物的用途。所述组合物和方法对于治疗由异常细胞信号传导介导的疾病，如炎症性疾病、癌症和肿瘤性疾病，是有用的。
• Novel polytriazine compounds
  申请人：Chimosa Chimica Organica S.p.A.

  公开号：US04086204A1

  公开（公告）日：1978-04-25

  Novel tetraalkyl piperidine radical containing polytriazine compounds are produced by reacting a dihalogen-triazine with a bifunctional compound containing amine, alcohol, mercaptan or phenol groups at least one of the bifunctional compounds containing a tetraalkyl piperidine radical. The compounds are valuable light stabilizers for synthetic polymers, particularly polyolefin in the form of fibers or films.

  通过将二卤代三嗪与含有胺、醇、巯基或酚基的双官能化合物反应，制备了含有四烷基哌啶基团的聚三嗪化合物。这些化合物是合成聚合物，特别是聚烯烃纤维或薄膜的有价值的光稳定剂。
• [EN] DISUBSTITUTED TRIAZINE DIMERS FOR TREATMENT AND/OR PREVENTION OF INFECTIOUS DISEASES<br/>[FR] DIMÈRES DE TRIAZINE DISUBSTITUÉE POUR LE TRAITEMENT E/OU LA PRÉVENTION DE MALADIES INFECTIEUSES
  申请人：UNIV ANTWERPEN

  公开号：WO2013068551A1

  公开（公告）日：2013-05-16

  The present invention relates to novel compounds (I) containing two disubstituted triazine rings covalently linked by an organic linker, thereby creating dimers. These compounds show activity against the causative infective agents of infectious diseases such as African trypanosomiasis, Chagas disease, Leishmaniasis, Malaria and HIV. The invention further relates to the prevention and/or treatment of these diseases.

  本发明涉及一种新型化合物（I），其中包含通过有机连接剂共价连接的两个二取代三嗪环，从而形成二聚体。这些化合物对致病的传染病如非洲锥虫病、克氏病、利什曼病、疟疾和艾滋病的感染性病原体表现出活性。该发明还涉及预防和/或治疗这些疾病。
• Therapeutic compounds
  申请人：CELGENE QUANTICEL RESEARCH, INC.

  公开号：US10202360B2

  公开（公告）日：2019-02-12

  The present disclosure relates to substituted heterocyclic derivative therapeutic compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of diseases mediated by aberrant cell signalling, such as inflammatory disorders, cancer and neoplastic disease.

  本公开涉及取代的杂环衍生物治疗化合物、包含所述化合物的组合物，以及所述化合物和组合物通过抑制溴化链介导的对蛋白质（如组蛋白）乙酰赖氨酸区的识别进行表观遗传调控的用途。所述组合物和方法可用于治疗由异常细胞信号介导的疾病，如炎症性疾病、癌症和肿瘤性疾病。
• Targeting the hydrophobic region of Hsp90’s ATP binding pocket with novel 1,3,5-triazines
  作者：Taeho Lee、Young Ho Seo

  DOI：10.1016/j.bmcl.2013.09.050

  日期：2013.12

  Heat shock protein 90 (Hsp90) is a molecular chaperone that plays an important role in regulating the maturation and stabilization of many oncogenic proteins. In an attempt to discover a new class of Hsp90 inhibitors, a series of 1,3,5-triazine compounds were rationally designed, synthesized, and their biological activities were evaluated. Compound 3b was found to degrade Hsp90's client proteins of Her2, Met and Akt and to induce the expression level of Hsp70. The binding mode of 3b in the ATP-binding site of Hsp90 was predicted by the molecular docking. (C) 2013 Elsevier Ltd. All rights reserved.